Bonzun: Merger with L2S a favorable reconfiguration for Bonzun’s shareholders - Emergers

Bonzun has agreed to sell all shares in its subsidiary Bonzun Evolve to CBT-based sleep therapy company Learning to Sleep (L2S, listed on First North) for a consideration of 311.2m newly emitted shares in L2S, equivalent to a value of SEK 31.1m or SEK 0.25 per Bonzun share. The deal will give Bonzun 77% of the shares in the combined company, after which the L2S shares will be distributed to Bonzun’s shareholders and the current CEO of Bonzun will become CEO of L2S. This will expand and strengthen both companies’ offerings, while also paving the way to build a new business fully focussed on digital CBT-based mental health.

Länk till analysen i sin helhet: https://www.emergers.se/bonzun_23i/